Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Statement

10 Dec 2015 07:00

RNS Number : 5796I
PZ CUSSONS PLC
10 December 2015
 

10 December 2015

PZ Cussons Plc

(the "Group")

 

Trading Update

 

PZ Cussons Plc announces its trading update in respect of the half year to 30 November 2015.

 

Overview

 

Group operating profits were broadly flat versus the comparative period with a strong performance in Europe offsetting a difficult trading environment in Nigeria and the impact of weaker currencies in both Asia and Africa.

 

The strength of the Group's innovative product pipeline and the positive impact of new launches are ensuring our market share positions are held or grown in our major markets and categories.

 

Performance in certain categories in Nigeria in the second half is likely to continue to be affected by the ongoing squeeze on consumer disposable income and by the tight environment of foreign exchange liquidity.

 

First half trading

 

Europe

 

In the UK, performance in the washing and bathing division has been strong, driven by a continuous innovation pipeline and the launch of a new range of Carex bodywash products.

 

The beauty division has performed particularly well across its key markets with St Tropez's new in shower gradual tan lotion generating strong sales and the Sanctuary brand benefiting from a new #LetGo campaign as well as the launch of new ranges.

 

Performance in the smaller markets of Poland and Greece was in line with expectations.

 

Asia

 

Despite the challenges of increased costs from weaker exchange rates, reduced consumer disposable income and reduced results on translation to sterling, we have made good progress overall across our Asian markets.

 

In Australia, performance has been good across personal care, beauty and the food & nutrition brands Rafferty's Garden and five:am, whilst trading conditions in the homecare category remain challenging.

 

In Indonesia, revenue growth has continued to be strong despite the more challenging consumer environment as a result of slower GDP growth and a weaker exchange rate.

 

In the smaller Asian markets, Thailand has performed well whilst Middle East performance is marginally lower.

 

Africa

 

In Nigeria, whilst the exchange rate has remained stable against the dollar, low oil prices continue to contribute to an environment of tight liquidity with additional foreign exchange restrictions imposed for certain imported items.

 

Whilst performance in the home and personal care business has been robust despite an extremely competitive environment, revenue and profits in the electricals business are significantly lower as a result of the squeeze on consumer disposable income. Performance in the Nutricima milk business has been strong in the first half. The PZ Wilmar edible oil joint venture has also performed well in the first half although currency liquidity is now beginning to impact the business.

 

In the smaller African markets, Kenya has performed in line with expectations whilst continued currency volatility has affected profitability in Ghana.

 

Full year outlook

 

The strength of the Group's brand portfolio and innovation pipeline continues to ensure that the market shares of our products remain strong in all markets.

 

Performance in Europe and Asia is expected to continue to be robust in the second half.

 

In Nigeria, the home and personal care and milk businesses are expected to continue to perform well. However, if current economic conditions persist, performance in the electricals business during the seasonal second half is expected to be significantly lower and trading in the PZ Wilmar joint venture will be impacted by restrictions on foreign exchange liquidity.

 

The Group's balance sheet remains strong and well placed to pursue new opportunities as they arise.

 

Interim Announcement

 

Interim results for the half year to 30 November 2015 will be announced on Tuesday 26th January 2016.

 

An analysts' presentation will be given at 9:30am on that day at the offices of Instinctif Partners, 65 Gresham Street, London, EC2V 7NQ.

 

- ENDS -

For further information contact:

PZ Cussons Plc

Brandon Leigh - Chief Financial Officer

 

Tel: 0161 435 1236

 

Instinctif

Tim Linacre / Guy Scarborough

 

Tel: 020 7457 2020

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUKVBRVSAURAA
Date   Source Headline
29th Jun 202311:06 amRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSTrading Statement
21st Jun 20239:59 amRNSDirector/PDMR Shareholding
16th Jun 20237:00 amRNSDirectorate Change
19th May 20239:27 amRNSDirector/PDMR Shareholding
21st Apr 20239:00 amRNSIntention to Conduct Audit Tender
19th Apr 202310:01 amRNSDirector/PDMR Shareholding
13th Apr 20233:18 pmRNSHolding(s) in Company
13th Apr 20237:00 amRNSQ3 Trading Update
12th Apr 20232:18 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSDirectorate Change
21st Mar 20239:30 amRNSDirector/PDMR Shareholding
17th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20239:31 amRNSDirector/PDMR Shareholding
8th Feb 20237:00 amRNS2023 Interim Results
19th Jan 20234:20 pmRNSDirector/PDMR Shareholding
20th Dec 20222:40 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:55 pmRNSDirector/PDMR Shareholding
24th Nov 20223:24 pmRNSResult of AGM
24th Nov 20227:00 amRNSDirectorate Change
21st Nov 20223:21 pmRNSDirector/PDMR Shareholding
14th Nov 20227:00 amRNSNew Credit Facility Linked to B Corp Ambitions
18th Oct 20223:52 pmRNSDirector/PDMR Shareholding
14th Oct 20227:00 amRNSPublication of Annual Report and Notice of AGM
27th Sep 202210:52 amRNSDirector/PDMR Shareholding
23rd Sep 20223:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNS2022 Full Year Results
21st Sep 202210:06 amRNSDirector Declaration
2nd Sep 202210:29 amRNSHolding(s) in Company
19th Aug 202210:05 amRNSDirector/PDMR Shareholding
29th Jul 20229:46 amRNSDirector/PDMR Shareholding
20th Jul 20223:21 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update
21st Jun 20224:10 pmRNSDirector/PDMR Shareholding
20th May 202210:30 amRNSFurther re 2021 AGM voting results
19th May 20225:45 pmRNSDirector/PDMR Shareholding
21st Apr 202210:30 amRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSTrading Statement
1st Apr 20229:00 amRNSDirector/PDMR Shareholding
25th Mar 202210:00 amRNSDirector/PDMR Shareholding
23rd Mar 20229:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:15 amRNSDirector/PDMR Shareholding
21st Mar 20227:00 amRNSAcquisition of Childs Farm
21st Feb 202211:00 amRNSDirector/PDMR Shareholding
11th Feb 20229:25 amRNSDirector/PDMR Shareholding
11th Feb 20229:15 amRNSBoard update
9th Feb 20227:00 amRNSHalf-year Report
19th Jan 202210:10 amRNSDirector/PDMR Shareholding
20th Dec 20214:35 pmRNSDirector/PDMR Shareholding
9th Dec 20219:38 amRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.